Life Sciences/ Healthcare

Alexandros Kortesis and team represented a leading medical devices company in litigation proceedings for claims related to clientele compensation and damages, with a value of 1,1m.

Alexandros Kortesis and team advised a multinational leading medical devices company on entering on DA with local distributor.

Alexandros Kortesis and team represented a leading medical devices company on dispute arising from public procurement proceedings set up by National General Hospital with a total value of €900k.

Alexandros Kortesis and team represented a multinational company in the pharmaceuticals sector in litigation proceedings against Minister of Health regarding the imposition of clawback of 2019 with a total value of €9m.

Alexandros Kortesis and team represented a multinational company in the pharmaceuticals sector in litigation proceedings against Minister of Health regarding the imposition of clawback with a total value of €4m.

Alexandros Kortesis and team advised and represented a leading multinational pharmaceutical company on the collection of 375k, claim against social insurance institute.

Alexandros Kortesis and team is defending a leading medical devices company, against a lawsuit on a dispute arising from a distribution agreement.

Alexandros Kortesis and team advised a multinational company on the regulatory framework of pharmaceutical cannabis in Greek market

Alexandros Kortesis and team advised a multinational company on the regulatory framework of industrial cannabis, in Greek market

Alexandros Kortesis and team advised the local arm of a multinational pharmaceutical company before the Negotiation Committee of Ministry of Health.

Alexandros Kortesis and team advised the local arm of a multinational leading pharmaceutical company on the transfer of assets of a cardiovascular business.

Alexandros Kortesis and team advised a multinational company on the regulatory framework of the e-cigarette, in Greek market

Alexandros Kortesis and team represented a leading multinational medical devices company on a dispute arising from a public procurement proceeding set up by the National Procurement Committee of the Ministry of Health for the supply of National Hospitals with intracoronary stents and angioplasty balloons, with a value of €15m.

Alexandros Kortesis and team represented a leading medical devices company on disputes arising from public procurement proceedings set up by National General Hospitals for the supply with artificial-kidney units for haemofiltration and haemodiafiltration.

George Bersis and team advised a leading global alternative investment management firm with expertise in credit strategies for the acquisition of the majority shareholding of a leading healthcare listed company and the refinancing of its debt

Alexandros Kortesis and team represented a leading multinational medical devices company on a dispute arising from a public procurement proceeding set up by the National Procurement Committee of the Ministry of Health for the supply of National Hospitals with pacemakers and defibrillators, with a value of €39m.

Alexandros Kortesis and team advised a multinational pharmaceutical group for the submission of a bid for the acquisition of a leading consumer health business portfolio of iconic and trusted brands across Pain, Cold & Flu, and other over-the-counter categories, in a number of countries, including Greece. The estimated value of the transaction was 1,6 bn Euros.

Alexandros Kortesis and his team advised the local arm of two multinational leading pharmaceutical companies on the transfer of assets of a gastroenterology medicine for patients with mild to moderate Crohn’s disease and ulcerative colitis in Greece with an estimated global value of $215m.

Alexandros Kortesis and team advised the local arm of a multinational leading pharmaceutical company on the acquisition of the assets of a respiratory business, with a global value of $577.7m.

Alexandros Kortesis and team represented a leading multinational medical devices company on a dispute arising from a public procurement proceeding set up by the National Procurement Committee of the Ministry of Health for the supply of National Hospitals with intracoronary stents and angioplasty balloons, with a value of €39 m.

Alexandros Kortesis and team advised the local arm of a multinational leading pharmaceutical company on the transfer of assets of an oncology business, with a global value of $165m.

Alexandros Kortesis and team represented a leading multinational medical devices company on a dispute arising from a public procurement tender set up by a hospital for the supply of cardiology material, with a value of €9.6m.

Alexandros Kortesis and team advised a multinational pharmaceutical company in their participation in public procurement tenders set up by the National Procurement Committee of the Ministry of Health for the supply of National Hospitals with pharmaceutical products with total budget of c.€26m.

Alexandros Kortesis and team advised the local arm of a multinational generic pharmaceutical company on the acquisition of a branded specialty and generics business.

Alexandros Kortesis and team advised a leading multinational medical devices and medical technology company in their participation in public procurement tenders set up by the National Procurement Committee of the Ministry of Health for the supply of National Hospitals with pacemakers and defibrillators with a budget of c.€39m.

Alexandros Kortesis and team advised a pharmaceutical company in their participation in two public procurement tenders set up by the Ministry of Health for the supply of National Hospitals with pharmaceutical products in January 2015 and December 2014, with budgets of c.€15m and c.€33m respectively.

Alexandros Kortesis and team advised a medical devices and medical technology company in their participation in public procurement tenders set up by the Ministry of Health for the supply of National Hospitals with intracoronary stents and angioplasty balloons with a budget of c.€39m, heart valves with a budget of c.€15m, and pacemakers and defibrillators with a budget of c.€45.

Alexandros Kortesis and team advised a publishing company in their participation in a public procurement tender held by the Ministry of Education and Religion for the printing and binding of first grade and second grade educational books for the 2015-2016 school year, with a total budgeted expenditure of c.€7m.

Alexandros Kortesis and team advised the local affiliate of a multinational pharmaceutical company in the acquisition and transfer of assets of a diabetes business in Greece.